Stay updated on Tuspetinib in AML: Safety & Efficacy Clinical Trial

Sign up to get notified when there's something new on the Tuspetinib in AML: Safety & Efficacy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tuspetinib in AML: Safety & Efficacy Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page now displays the tuspetinib study record, including its study details and recruitment information, in place of the 403 error view.
    Difference
    100%
    Check dated 2026-11-08T13:32:29.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now displays revision v3.8.0 instead of v3.7.2. The page still shows a 403 Forbidden error rather than the study record.
    Difference
    0.2%
    Check dated 2026-11-01T14:38:34.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces a transition notice about using “Super Intelligence” in place of “Artificial Intelligence” across NIH content. The underlying page still displays a 403 Forbidden error.
    Difference
    1%
    Check dated 2026-10-25T14:43:42.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.1 to v3.7.2 while the page remains a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T14:47:13.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The footer revision identifier updates from v3.7.0 to v3.7.1 while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-11T14:29:59.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, replacing the usual study details; this indicates an access restriction rather than an update to the study data.
    Difference
    23%
    Check dated 2026-09-20T11:23:44.000Z thumbnail image

Stay in the know with updates to Tuspetinib in AML: Safety & Efficacy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tuspetinib in AML: Safety & Efficacy Clinical Trial page.